BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21088286)

  • 1. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R; Light RP
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):528-36. PubMed ID: 21088286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K; Kenttä T; Niiranen TJ; Nieminen MS; Oikarinen L; Viitasalo M; Hernesniemi J; Jula AM; Salomaa V; Huikuri HV; Albert CM; Tikkanen JT
    Int J Cardiol; 2019 Feb; 276():125-129. PubMed ID: 30293667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of electrocardiographic left ventricular hypertrophy in the general population: A meta-analysis.
    You Z; He T; Ding Y; Yang L; Jiang X; Huang L
    J Electrocardiol; 2020; 62():14-19. PubMed ID: 32745730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Electrocardiography to Predict Future Development of Hypertension in the General Population.
    Takase H; Sugiura T; Murai S; Yamashita S; Ohte N; Dohi Y
    Medicine (Baltimore); 2016 Apr; 95(17):e3483. PubMed ID: 27124047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC; Okin PM; Devereux RB; Olsen MH; Ibsen H; Dahlöf B; Kjeldsen SE; Wachtell K
    J Hum Hypertens; 2011 Mar; 25(3):178-85. PubMed ID: 20505749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional impact of electrocardiographic over echocardiographic diagnosis of left ventricular hypertrophy for predicting the risk of ischemic stroke.
    Kohsaka S; Sciacca RR; Sugioka K; Sacco RL; Homma S; Di Tullio MR
    Am Heart J; 2005 Jan; 149(1):181-6. PubMed ID: 15660051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy assessed by electrocardiogram is associated with more severe stroke and with higher in-hospital mortality in patients with acute ischemic stroke.
    Tziomalos K; Sofogianni A; Angelopoulou SM; Christou K; Kostaki S; Papagianni M; Satsoglou S; Spanou M; Savopoulos C; Hatzitolios AI
    Atherosclerosis; 2018 Jul; 274():206-211. PubMed ID: 29800790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of stroke with electrocardiographic left ventricular hypertrophy in hypertensive patients: A meta-analysis.
    Yi S; Wang F; Wan M; Yi X; Zhang Y; Sun S
    J Electrocardiol; 2020; 61():27-31. PubMed ID: 32504899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of left ventricular hypertrophy in hypertensive patients: A meta-analysis of electrocardiographic studies.
    Zhang H; Hu L; Wei X
    J Clin Hypertens (Greenwich); 2020 Feb; 22(2):254-260. PubMed ID: 31955500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease.
    Cordeiro AC; Lindholm B; Sousa MG; Picotti JC; Nunes GJ; Santana MR; Grimaldi W; Amparo FC; Amodeo C; Carrero JJ
    J Hypertens; 2014 Feb; 32(2):439-45. PubMed ID: 24317549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.